Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (4)

Merz (United States): Raleigh, North Carolina, US

2023-07-17 to present | Medical Affairs Specialist (Global Medical Affairs, Scientific Communications)
Employment
Source: Self-asserted source
Matthew Jackson

Bentley University: Waltham, MA, US

2019-12-01 to 2023-07 | Postdoctoral Fellow (Center for Integration of Science and Industry)
Employment
Source: Self-asserted source
Matthew Jackson

Bentley University: Waltham, MA, US

2020-01 to 2022-09 | Adjunct Professor, Human Biology (Natural and Applied Sciences)
Employment
Source: Self-asserted source
Matthew Jackson

Hexis Lab Ltd: Newcastle Upon Tyne, N/A, GB

2018-09 to 2019-09 | Knowledge Transfer Partnership Postdoctoral Associate
Employment
Source: Self-asserted source
Matthew Jackson

Education and qualifications (3)

Newcastle University: Newcastle upon Tyne, Tyne and Wear, GB

2015-09 to 2018-12 | Philosophical Doctorate, Cellular Medicine (Dermatological Sciences)
Education
Source: Self-asserted source
Matthew Jackson

University of Glasgow: Glasgow, Glasgow, GB

2014-09 to 2015-09 | MSc, Stratified Medicine & Pharmacological Innovation
Education
Source: Self-asserted source
Matthew Jackson

University of Dundee: Dundee, Dundee, GB

2008-09 to 2012-05 | BSc (Hons), Pharmacology
Education
Source: Self-asserted source
Matthew Jackson

Professional activities (3)

Medical Affairs Professional Society (MAPS): Golden, Colorado, US

2023-11 to present
Membership
Source: Self-asserted source
Matthew Jackson

International Society for Medical Publication Professionals: New York, New York, US

2023-10 to present
Membership
Source: Self-asserted source
Matthew Jackson

British Association of Dermatologists: London, GB

2017 to present
Membership
Source: Self-asserted source
Matthew Jackson

Works (11)

Microfocused Ultrasound in Regenerative Aesthetics: A Narrative Review on Mechanisms of Action and Clinical Outcomes

Journal of Cosmetic Dermatology
2025-02 | Journal article
DOI: 10.1111/jocd.16658
Contributors: Vasanop Vachiramon; Tatjana Pavicic; Gabriela Casabona; Jeremy B. Green; Jennifer Levine; Je‐Young Park; Julieta Spada; Mariana Muniz; John Akers; Matthew Jackson et al.
Source: check_circle
Crossref

Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration, 2010–2019: a cross-sectional analysis

BMJ Open
2024-03 | Journal article
DOI: 10.1136/bmjopen-2023-076542
Contributors: Matthew J Jackson; Gregory Vaughan; Fred D Ledley
Source: check_circle
Crossref

Spending on Phased Clinical Development of Approved Drugs by the US National Institutes of Health Compared With Industry

JAMA Health Forum
2023-07-14 | Journal article
DOI: 10.1001/jamahealthforum.2023.1921
Part of ISSN: 2689-0186
Contributors: Edward W. Zhou; Matthew J. Jackson; Fred D. Ledley
Source: Self-asserted source
Matthew Jackson

Association between expedited review designations and the US or global burden of disease for drugs approved by the US Food and Drug Administration 2010–2019

2023-06-04 | Preprint
DOI: 10.1101/2023.06.01.23290833
Contributors: Matthew J. Jackson; Gregory Vaughan; Fred D. Ledley
Source: check_circle
Crossref

NIH funding for vaccine readiness before the COVID-19 pandemic

Vaccine
2021-04 | Journal article
DOI: 10.1016/j.vaccine.2021.03.022
Contributors: Anthony E. Kiszewski; Ekaterina Galkina Cleary; Matthew J. Jackson; Fred D. Ledley
Source: check_circle
Crossref

The role of NIH funding in vaccine readiness; foundational research and NIH funding underlying candidate SARS-CoV-2 vaccines

2020-09-09 | Other
DOI: 10.1101/2020.09.08.20187559
Contributors: Anthony E Kiszewski; Ekaterina Galkina Cleary; Matthew J Jackson; Fred D Ledley
Source: check_circle
Crossref

Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019

Institute for New Economic Thinking Working Paper Series
2020-09-01 | Journal article
DOI: 10.36687/inetwp133
Contributors: Ekaterina Galkina Cleary; Matthew J. Jackson; Fred D. Ledley
Source: check_circle
Crossref

Foundational research and NIH funding enabling Emergency Use Authorization of remdesivir for COVID-19

2020-07-06 | Other
DOI: 10.1101/2020.07.01.20144576
Contributors: Ekaterina Galkina Cleary; Matthew J. Jackson; Zoë Folchman-Wagner; Fred D. Ledley
Source: check_circle
Crossref

Taxpayer Investment Leads New Drug Discoveries

Institute for New Economic Thinking
2020-03 | Report
Source: Self-asserted source
Matthew Jackson

CHAPTER 5. Oxidative Stress, Metabolism and Photoaging – The Role of Mitochondria

Comprehensive Series in Photochemical & Photobiological Sciences
2019-08-22 | Book chapter
DOI: 10.1039/9781788015981-00105
Part of ISBN: 9781788011266
Part of ISSN: 2041-9724
Source: Self-asserted source
Matthew Jackson

The impact of environmental pressures on cellular bioenergetics in ageing human skin

Journal of Investigative Dermatology
2017-05-01 | Journal article
Source: Self-asserted source
Matthew Jackson
How many people are using ORCID?